Combo Rx for Fibromyalgia Tied to Higher Adherence
However, combination prescription initiation also tied to higher health care costs
MTX + Adalimumab Beneficial in JIA-Associated Uveitis
In children with active juvenile idiopathic arthritis, the combination controls eye inflammation
EHR Documentation May Help in Harm Reduction Initiatives
EHR-based initiative tied to more than 30 percent reduction in harm for hospital-acquired infections
Early RA Treatment Important for Long-Term Outcomes
Other study shows drop in mortality attributable to rheumatoid arthritis from 1987 to 2011
Three Anti-VEGF Treatments Effective for Diabetic Retinopathy
Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab
Regorafenib Approved for Hepatocellular Carcinoma
It is the first approved treatment for HCC in almost a decade
Single-Payer Health System Bill Moves Forward in California
Not yet clear where money for the single-payer system would come from
Many Patients With Alzheimer’s Disease Discontinue AChEIs
Adverse effects and cost account for most cases of discontinuation
Plasma Uric Acid Lowering Tied to Drop in Systolic BP in T1DM
Febuxostat has modest BP-lowering effect, with no impact on arterial stiffness, urinary nitric oxide
Postbiotic Could Lower Glucose, Inflammation in Obesity
MDP postbiotic linked to reduction in hepatic insulin resistance during obesity, low-level endotoxemia
